OPTISCHE BESTIMMUNG DER BLUTPERFUSION UND ÄHNLICHER PARAMETER

European patent · EP2563207 · In force

Register entry

Publication number
EP2563207
Application number
EP10707430
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Feb 26, 2010
Published
Mar 6, 2013
Granted
Nov 13, 2019
Protection ends at the latest
Feb 25, 2030
Next annual fee due
Feb 28, 2027
IPC classes
A61B 5/00 (2006.01)
PCT application
PCT/CH2010/000049 26.02.2010
PCT publication
WO2011/103690 01.09.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 1, 2026

    Change

    Published in Swissreg on 01.03.2026

  2. Jul 10, 2025

    Change

    Published in Swissreg on 10.07.2025

  3. Mar 1, 2024

    Change

    Published in Swissreg on 01.03.2024

  4. Dec 21, 2023

    Address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 21.12.2023

  5. Mar 6, 2023

    Change

    Published in Swissreg on 06.03.2023

  6. Apr 16, 2020

    Transferred

    Owner
    Biovotion AG, Technoparkstrasse 1, 8005 Zürich → Biosigns Pte Ltd., 2 Venture Drive, #23-01 Vision Exchange, Singapore 608526, Singapore

    Published in Swissreg on 16.04.2020

  7. Jan 11, 2020

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 11.01.2020

  8. Nov 13, 2019

    Granted

    Published in Swissreg on 13.11.2019

Parties

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.